Quiz Answer Choice. After publication, the online version of the article, “Evidence-Based Contraception: Common Questions and Answers” (September 2022, p. 251), was updated to include information from the U.S. Food and Drug Administration from August 2022 that extended the recommended duration of use for the levonorgestrel-releasing intrauterine system, 52 mg, (Mirena) to eight years. This update should also have been included in the online version of the CME Quiz for the September 2022 issue. In Question 2, answer choice D has been updated to the following: “Levonorgestrel-releasing intrauterine system, 52 mg, (Mirena) for eight years.”